7-56073066-CTT-C
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP6_ModerateBS1BS2
The NM_015411.4(SUMF2):βc.296_297delβ(p.Phe99CysfsTer3) variant causes a frameshift change. The variant allele was found at a frequency of 0.00175 in 1,614,192 control chromosomes in the GnomAD database, including 50 homozygotes. Variant has been reported in ClinVar as Benign (β ). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: π 0.0094 ( 20 hom., cov: 31)
Exomes π: 0.00096 ( 30 hom. )
Consequence
SUMF2
NM_015411.4 frameshift
NM_015411.4 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 7.18
Genes affected
SUMF2 (HGNC:20415): (sulfatase modifying factor 2) The catalytic sites of sulfatases are only active if they contain a unique amino acid, C-alpha-formylglycine (FGly). The FGly residue is posttranslationally generated from a cysteine by enzymes with FGly-generating activity. The gene described in this record is a member of the sulfatase-modifying factor family and encodes a protein with a DUF323 domain that localizes to the lumen of the endoplasmic reticulum. This protein has low levels of FGly-generating activity but can heterodimerize with another family member - a protein with high levels of FGly-generating activity. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP6
Variant 7-56073066-CTT-C is Benign according to our data. Variant chr7-56073066-CTT-C is described in ClinVar as [Benign]. Clinvar id is 709121.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00936 (1425/152312) while in subpopulation AFR AF= 0.0318 (1322/41558). AF 95% confidence interval is 0.0304. There are 20 homozygotes in gnomad4. There are 684 alleles in male gnomad4 subpopulation. Median coverage is 31. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 20 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SUMF2 | NM_015411.4 | c.296_297del | p.Phe99CysfsTer3 | frameshift_variant | 3/9 | ENST00000434526.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SUMF2 | ENST00000434526.8 | c.296_297del | p.Phe99CysfsTer3 | frameshift_variant | 3/9 | 1 | NM_015411.4 | P2 |
Frequencies
GnomAD3 genomes AF: 0.00932 AC: 1419AN: 152194Hom.: 20 Cov.: 31
GnomAD3 genomes
AF:
AC:
1419
AN:
152194
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00251 AC: 630AN: 251488Hom.: 12 AF XY: 0.00199 AC XY: 270AN XY: 135920
GnomAD3 exomes
AF:
AC:
630
AN:
251488
Hom.:
AF XY:
AC XY:
270
AN XY:
135920
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000961 AC: 1405AN: 1461880Hom.: 30 AF XY: 0.000835 AC XY: 607AN XY: 727242
GnomAD4 exome
AF:
AC:
1405
AN:
1461880
Hom.:
AF XY:
AC XY:
607
AN XY:
727242
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00936 AC: 1425AN: 152312Hom.: 20 Cov.: 31 AF XY: 0.00918 AC XY: 684AN XY: 74484
GnomAD4 genome
AF:
AC:
1425
AN:
152312
Hom.:
Cov.:
31
AF XY:
AC XY:
684
AN XY:
74484
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
10
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Invitae | Feb 04, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at